世界のバーター症候群治療市場規模・現状・予測2021-2027

【英語タイトル】Global Bartter Syndrome Treatment Market Size, Status and Forecast 2021-2027

QYResearchが出版した調査資料(QY21APR0705)・商品コード:QY21APR0705
・発行会社(調査会社):QYResearch
・発行日:2021年4月(※2024年版があります。お問い合わせください)
・ページ数:93
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査資料では、バーター症候群治療の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(NSAID(非ステロイド性抗炎症薬)、RAAS阻害剤、アルドステロン拮抗薬、アンジオテンシンII受容体拮抗薬、アンジオテンシン変換酵素(ACE)阻害薬、その他)、用途別市場規模(病院薬局、小売薬局、オンライン薬局)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・バーター症候群治療の市場動向
・企業の競争状況、市場シェア
・バーター症候群治療の種類別市場規模(NSAID(非ステロイド性抗炎症薬)、RAAS阻害剤、アルドステロン拮抗薬、アンジオテンシンII受容体拮抗薬、アンジオテンシン変換酵素(ACE)阻害薬、その他)
・バーター症候群治療の用途別市場規模(病院薬局、小売薬局、オンライン薬局)
・バーター症候群治療の北米市場規模2016-2027(アメリカ、カナダ)
・バーター症候群治療の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・バーター症候群治療のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・バーター症候群治療の中南米市場規模2016-2027(メキシコ、ブラジル)
・バーター症候群治療の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Abbott Laboratories、Novartis、Pfizer、Eli Lilly、Bristol-Myers Squibb)
・結論
【レポートの概要】

Bartter syndrome is a rare genetic disorder that causes specific defects in kidney function.
The global market for Bartter syndrome treatment is expected to witness a moderate growth rate over the forecast period.

Market Analysis and Insights: Global Bartter Syndrome Treatment Market
The global Bartter Syndrome Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Bartter Syndrome Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Bartter Syndrome Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Bartter Syndrome Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Bartter Syndrome Treatment market.

Global Bartter Syndrome Treatment Scope and Market Size
Bartter Syndrome Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Bartter Syndrome Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
NSAIDs (Nonsteroidal Anti-inflammatory Drugs)
RAAS Inhibitors
Aldosterone Antagonists
Angiotensin II Receptor Blockers
Angiotensin-Converting Enzyme (ACE) Inhibitors
Others

Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Abbott Laboratories
Novartis
Pfizer
Eli Lilly
Bristol-Myers Squibb

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bartter Syndrome Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 NSAIDs (Nonsteroidal Anti-inflammatory Drugs)
1.2.3 RAAS Inhibitors
1.2.4 Aldosterone Antagonists
1.2.5 Angiotensin II Receptor Blockers
1.2.6 Angiotensin-Converting Enzyme (ACE) Inhibitors
1.2.7 Others
1.3 Market by Application
1.3.1 Global Bartter Syndrome Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Bartter Syndrome Treatment Market Perspective (2016-2027)
2.2 Bartter Syndrome Treatment Growth Trends by Regions
2.2.1 Bartter Syndrome Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Bartter Syndrome Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Bartter Syndrome Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Bartter Syndrome Treatment Industry Dynamic
2.3.1 Bartter Syndrome Treatment Market Trends
2.3.2 Bartter Syndrome Treatment Market Drivers
2.3.3 Bartter Syndrome Treatment Market Challenges
2.3.4 Bartter Syndrome Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Bartter Syndrome Treatment Players by Revenue
3.1.1 Global Top Bartter Syndrome Treatment Players by Revenue (2016-2021)
3.1.2 Global Bartter Syndrome Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Bartter Syndrome Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Bartter Syndrome Treatment Revenue
3.4 Global Bartter Syndrome Treatment Market Concentration Ratio
3.4.1 Global Bartter Syndrome Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bartter Syndrome Treatment Revenue in 2020
3.5 Bartter Syndrome Treatment Key Players Head office and Area Served
3.6 Key Players Bartter Syndrome Treatment Product Solution and Service
3.7 Date of Enter into Bartter Syndrome Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Bartter Syndrome Treatment Breakdown Data by Type
4.1 Global Bartter Syndrome Treatment Historic Market Size by Type (2016-2021)
4.2 Global Bartter Syndrome Treatment Forecasted Market Size by Type (2022-2027)

5 Bartter Syndrome Treatment Breakdown Data by Application
5.1 Global Bartter Syndrome Treatment Historic Market Size by Application (2016-2021)
5.2 Global Bartter Syndrome Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Bartter Syndrome Treatment Market Size (2016-2027)
6.2 North America Bartter Syndrome Treatment Market Size by Type
6.2.1 North America Bartter Syndrome Treatment Market Size by Type (2016-2021)
6.2.2 North America Bartter Syndrome Treatment Market Size by Type (2022-2027)
6.2.3 North America Bartter Syndrome Treatment Market Size by Type (2016-2027)
6.3 North America Bartter Syndrome Treatment Market Size by Application
6.3.1 North America Bartter Syndrome Treatment Market Size by Application (2016-2021)
6.3.2 North America Bartter Syndrome Treatment Market Size by Application (2022-2027)
6.3.3 North America Bartter Syndrome Treatment Market Size by Application (2016-2027)
6.4 North America Bartter Syndrome Treatment Market Size by Country
6.4.1 North America Bartter Syndrome Treatment Market Size by Country (2016-2021)
6.4.2 North America Bartter Syndrome Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Bartter Syndrome Treatment Market Size (2016-2027)
7.2 Europe Bartter Syndrome Treatment Market Size by Type
7.2.1 Europe Bartter Syndrome Treatment Market Size by Type (2016-2021)
7.2.2 Europe Bartter Syndrome Treatment Market Size by Type (2022-2027)
7.2.3 Europe Bartter Syndrome Treatment Market Size by Type (2016-2027)
7.3 Europe Bartter Syndrome Treatment Market Size by Application
7.3.1 Europe Bartter Syndrome Treatment Market Size by Application (2016-2021)
7.3.2 Europe Bartter Syndrome Treatment Market Size by Application (2022-2027)
7.3.3 Europe Bartter Syndrome Treatment Market Size by Application (2016-2027)
7.4 Europe Bartter Syndrome Treatment Market Size by Country
7.4.1 Europe Bartter Syndrome Treatment Market Size by Country (2016-2021)
7.4.2 Europe Bartter Syndrome Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Bartter Syndrome Treatment Market Size (2016-2027)
8.2 Asia-Pacific Bartter Syndrome Treatment Market Size by Type
8.2.1 Asia-Pacific Bartter Syndrome Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Bartter Syndrome Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Bartter Syndrome Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Bartter Syndrome Treatment Market Size by Application
8.3.1 Asia-Pacific Bartter Syndrome Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Bartter Syndrome Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Bartter Syndrome Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Bartter Syndrome Treatment Market Size by Region
8.4.1 Asia-Pacific Bartter Syndrome Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Bartter Syndrome Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Bartter Syndrome Treatment Market Size (2016-2027)
9.2 Latin America Bartter Syndrome Treatment Market Size by Type
9.2.1 Latin America Bartter Syndrome Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Bartter Syndrome Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Bartter Syndrome Treatment Market Size by Type (2016-2027)
9.3 Latin America Bartter Syndrome Treatment Market Size by Application
9.3.1 Latin America Bartter Syndrome Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Bartter Syndrome Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Bartter Syndrome Treatment Market Size by Application (2016-2027)
9.4 Latin America Bartter Syndrome Treatment Market Size by Country
9.4.1 Latin America Bartter Syndrome Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Bartter Syndrome Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Bartter Syndrome Treatment Market Size (2016-2027)
10.2 Middle East & Africa Bartter Syndrome Treatment Market Size by Type
10.2.1 Middle East & Africa Bartter Syndrome Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Bartter Syndrome Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Bartter Syndrome Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Bartter Syndrome Treatment Market Size by Application
10.3.1 Middle East & Africa Bartter Syndrome Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Bartter Syndrome Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Bartter Syndrome Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Bartter Syndrome Treatment Market Size by Country
10.4.1 Middle East & Africa Bartter Syndrome Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Bartter Syndrome Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Bartter Syndrome Treatment Introduction
11.1.4 Abbott Laboratories Revenue in Bartter Syndrome Treatment Business (2016-2021)
11.1.5 Abbott Laboratories Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Bartter Syndrome Treatment Introduction
11.2.4 Novartis Revenue in Bartter Syndrome Treatment Business (2016-2021)
11.2.5 Novartis Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Bartter Syndrome Treatment Introduction
11.3.4 Pfizer Revenue in Bartter Syndrome Treatment Business (2016-2021)
11.3.5 Pfizer Recent Development
11.4 Eli Lilly
11.4.1 Eli Lilly Company Details
11.4.2 Eli Lilly Business Overview
11.4.3 Eli Lilly Bartter Syndrome Treatment Introduction
11.4.4 Eli Lilly Revenue in Bartter Syndrome Treatment Business (2016-2021)
11.4.5 Eli Lilly Recent Development
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Company Details
11.5.2 Bristol-Myers Squibb Business Overview
11.5.3 Bristol-Myers Squibb Bartter Syndrome Treatment Introduction
11.5.4 Bristol-Myers Squibb Revenue in Bartter Syndrome Treatment Business (2016-2021)
11.5.5 Bristol-Myers Squibb Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Bartter Syndrome Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of NSAIDs (Nonsteroidal Anti-inflammatory Drugs)
Table 3. Key Players of RAAS Inhibitors
Table 4. Key Players of Aldosterone Antagonists
Table 5. Key Players of Angiotensin II Receptor Blockers
Table 6. Key Players of Angiotensin-Converting Enzyme (ACE) Inhibitors
Table 7. Key Players of Others
Table 8. Global Bartter Syndrome Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Bartter Syndrome Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Bartter Syndrome Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Bartter Syndrome Treatment Market Share by Regions (2016-2021)
Table 12. Global Bartter Syndrome Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Bartter Syndrome Treatment Market Share by Regions (2022-2027)
Table 14. Bartter Syndrome Treatment Market Trends
Table 15. Bartter Syndrome Treatment Market Drivers
Table 16. Bartter Syndrome Treatment Market Challenges
Table 17. Bartter Syndrome Treatment Market Restraints
Table 18. Global Bartter Syndrome Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Bartter Syndrome Treatment Market Share by Players (2016-2021)
Table 20. Global Top Bartter Syndrome Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bartter Syndrome Treatment as of 2020)
Table 21. Ranking of Global Top Bartter Syndrome Treatment Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Bartter Syndrome Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Bartter Syndrome Treatment Product Solution and Service
Table 25. Date of Enter into Bartter Syndrome Treatment Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Bartter Syndrome Treatment Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Bartter Syndrome Treatment Revenue Market Share by Type (2016-2021)
Table 29. Global Bartter Syndrome Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Bartter Syndrome Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Bartter Syndrome Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Bartter Syndrome Treatment Revenue Market Share by Application (2016-2021)
Table 33. Global Bartter Syndrome Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Bartter Syndrome Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Bartter Syndrome Treatment Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Bartter Syndrome Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Bartter Syndrome Treatment Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Bartter Syndrome Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Bartter Syndrome Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Bartter Syndrome Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Bartter Syndrome Treatment Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Bartter Syndrome Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Bartter Syndrome Treatment Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Bartter Syndrome Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Bartter Syndrome Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Bartter Syndrome Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Bartter Syndrome Treatment Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Bartter Syndrome Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Bartter Syndrome Treatment Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Bartter Syndrome Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Bartter Syndrome Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Bartter Syndrome Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Bartter Syndrome Treatment Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Bartter Syndrome Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Bartter Syndrome Treatment Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Bartter Syndrome Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Bartter Syndrome Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Bartter Syndrome Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Bartter Syndrome Treatment Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Bartter Syndrome Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Bartter Syndrome Treatment Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Bartter Syndrome Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Bartter Syndrome Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Bartter Syndrome Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 65. Abbott Laboratories Company Details
Table 66. Abbott Laboratories Business Overview
Table 67. Abbott Laboratories Bartter Syndrome Treatment Product
Table 68. Abbott Laboratories Revenue in Bartter Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 69. Abbott Laboratories Recent Development
Table 70. Novartis Company Details
Table 71. Novartis Business Overview
Table 72. Novartis Bartter Syndrome Treatment Product
Table 73. Novartis Revenue in Bartter Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 74. Novartis Recent Development
Table 75. Pfizer Company Details
Table 76. Pfizer Business Overview
Table 77. Pfizer Bartter Syndrome Treatment Product
Table 78. Pfizer Revenue in Bartter Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 79. Pfizer Recent Development
Table 80. Eli Lilly Company Details
Table 81. Eli Lilly Business Overview
Table 82. Eli Lilly Bartter Syndrome Treatment Product
Table 83. Eli Lilly Revenue in Bartter Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 84. Eli Lilly Recent Development
Table 85. Bristol-Myers Squibb Company Details
Table 86. Bristol-Myers Squibb Business Overview
Table 87. Bristol-Myers Squibb Bartter Syndrome Treatment Product
Table 88. Bristol-Myers Squibb Revenue in Bartter Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 89. Bristol-Myers Squibb Recent Development
Table 90. Research Programs/Design for This Report
Table 91. Key Data Information from Secondary Sources
Table 92. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Bartter Syndrome Treatment Market Share by Type: 2020 VS 2027
Figure 2. NSAIDs (Nonsteroidal Anti-inflammatory Drugs) Features
Figure 3. RAAS Inhibitors Features
Figure 4. Aldosterone Antagonists Features
Figure 5. Angiotensin II Receptor Blockers Features
Figure 6. Angiotensin-Converting Enzyme (ACE) Inhibitors Features
Figure 7. Others Features
Figure 8. Global Bartter Syndrome Treatment Market Share by Application: 2020 VS 2027
Figure 9. Hospital Pharmacies Case Studies
Figure 10. Retail Pharmacies Case Studies
Figure 11. Online Pharmacies Case Studies
Figure 12. Bartter Syndrome Treatment Report Years Considered
Figure 13. Global Bartter Syndrome Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Bartter Syndrome Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Bartter Syndrome Treatment Market Share by Regions: 2020 VS 2027
Figure 16. Global Bartter Syndrome Treatment Market Share by Regions (2022-2027)
Figure 17. Global Bartter Syndrome Treatment Market Share by Players in 2020
Figure 18. Global Top Bartter Syndrome Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bartter Syndrome Treatment as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Bartter Syndrome Treatment Revenue in 2020
Figure 20. Global Bartter Syndrome Treatment Revenue Market Share by Type (2016-2021)
Figure 21. Global Bartter Syndrome Treatment Revenue Market Share by Type (2022-2027)
Figure 22. North America Bartter Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Bartter Syndrome Treatment Market Share by Type (2016-2027)
Figure 24. North America Bartter Syndrome Treatment Market Share by Application (2016-2027)
Figure 25. North America Bartter Syndrome Treatment Market Share by Country (2016-2027)
Figure 26. United States Bartter Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Bartter Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Bartter Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Bartter Syndrome Treatment Market Share by Type (2016-2027)
Figure 30. Europe Bartter Syndrome Treatment Market Share by Application (2016-2027)
Figure 31. Europe Bartter Syndrome Treatment Market Share by Country (2016-2027)
Figure 32. Germany Bartter Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Bartter Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Bartter Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Bartter Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Bartter Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Bartter Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Bartter Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Bartter Syndrome Treatment Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Bartter Syndrome Treatment Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Bartter Syndrome Treatment Market Share by Region (2016-2027)
Figure 42. China Bartter Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Bartter Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Bartter Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Bartter Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Bartter Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Bartter Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Bartter Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Bartter Syndrome Treatment Market Share by Type (2016-2027)
Figure 50. Latin America Bartter Syndrome Treatment Market Share by Application (2016-2027)
Figure 51. Latin America Bartter Syndrome Treatment Market Share by Country (2016-2027)
Figure 52. Mexico Bartter Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Bartter Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Bartter Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Bartter Syndrome Treatment Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Bartter Syndrome Treatment Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Bartter Syndrome Treatment Market Share by Country (2016-2027)
Figure 58. Turkey Bartter Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Bartter Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Bartter Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Abbott Laboratories Revenue Growth Rate in Bartter Syndrome Treatment Business (2016-2021)
Figure 62. Novartis Revenue Growth Rate in Bartter Syndrome Treatment Business (2016-2021)
Figure 63. Pfizer Revenue Growth Rate in Bartter Syndrome Treatment Business (2016-2021)
Figure 64. Eli Lilly Revenue Growth Rate in Bartter Syndrome Treatment Business (2016-2021)
Figure 65. Bristol-Myers Squibb Revenue Growth Rate in Bartter Syndrome Treatment Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed


【掲載企業】

Abbott Laboratories、Novartis、Pfizer、Eli Lilly、Bristol-Myers Squibb

★調査レポート[世界のバーター症候群治療市場規模・現状・予測2021-2027] (コード:QY21APR0705)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のバーター症候群治療市場規模・現状・予測2021-2027]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆